Skip to main content

Clinical decision support at the time of an e-prescription can sustainably decrease unwarranted use of antibiotics for acute respiratory infections

Description

Microorganisms resistant to antibiotics (ABX) increase the mortality, morbidity and costs of infections. In the absence of a drug development pipeline that can keep pace with the emerging resistancemechanisms, these organisms are expected to threaten public health for years to come. Because exposure to ABX promotes the development of bacterial resistance, health care providers have long been urged to avoid using antibiotics to treat conditions that they are unlikely to improve, including many uncomplicated acute respiratory infections. We asked if interposing clinical decision support software at the time of electronic order entry could adjust ABX utilization toward consensus guidelines for these conditions. 

Submitted by hparton on